My Legacy Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$628K Sell
2,283
-101
-4% -$27.5K 0.22% 123
2025
Q1
$632K Buy
2,384
+56
+2% +$13.8K 0.24% 120
2024
Q4
$531K Sell
2,328
-47
-2% -$10.8K 0.21% 129
2024
Q3
$524K Sell
2,375
-678
-22% -$140K 0.21% 127
2024
Q2
$600K Buy
3,053
+128
+4% +$26.4K 0.19% 138
2024
Q1
$630K Sell
2,925
-102
-3% -$21.4K 0.21% 135
2023
Q4
$595K Sell
3,027
-70
-2% -$14.9K 0.21% 139
2023
Q3
$663K Buy
3,097
+43
+1% +$8.55K 0.27% 115
2023
Q2
$560K Sell
3,054
-196
-6% -$36.2K 0.22% 140
2023
Q1
$626K Sell
3,250
-1,834
-36% -$332K 0.27% 131
2022
Q4
$898K Sell
5,084
-52
-1% -$9.04K 0.38% 90
2022
Q3
$882K Buy
5,136
+159
+3% +$31.4K 0.45% 70
2022
Q2
$1.04M Buy
4,977
+478
+11% +$101K 0.52% 55
2022
Q1
$1.07M Buy
+4,499
New +$1.06M 0.5% 55

Other funds holding CME

My Legacy Advisors's CME Position: Q2 2025 in Review

My Legacy Advisors reduced its CME Group (CME) stake by 4.2% in Q2 2025, selling an estimated $27.5K and leaving 2,283 shares worth $628K. The position accounts for 0.22% of the portfolio, ranked #123.

My Legacy Advisors first reported a position in CME in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.07M in Q1 2022. 1,660 funds tracked by Wall St. Rank hold CME as of Q2 2025.

  • My Legacy Advisors held 2,283 shares of CME Group worth $628K as of Q2 2025.
  • My Legacy Advisors sold 101 CME Group shares in Q2 2025, an estimated $27.5K.
  • CME Group made up 0.22% of My Legacy Advisors's portfolio in Q2 2025, its #123 holding.
  • My Legacy Advisors first reported a position in CME Group in Q1 2022 and has held it in 14 quarters since.
  • My Legacy Advisors's CME Group position peaked at $1.07M in Q1 2022.
  • 1,660 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on My Legacy Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.